Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Ceci

Showing results (41-50 of 148) with videos related to

Pageof 15
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|April 14, 2017
The role of <sup>18</sup>F-FDG PET/CT in the detection of osteosarcoma recurrenceAndrea Angelini, Francesco Ceci, Paolo Castellucci, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|June 11, 2024
Prostate cancer: nuclear medicine imaging in the biochemical recurrence and in oligometastatic diseaseLorenzo Muraglia, Egesta Lopci, Jelena Jandric, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 16, 2012
(11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomyFrancesco Ceci, Paolo Castellucci, Marcelo Mamede, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 8, 2019
Prediction nomogram for <sup>68</sup>Ga-PSMA-11 PET/CT in different clinical settings of PSA failure after radical treatment for prostate cancerFrancesco Ceci, Lorenzo Bianchi, Marco Borghesi, et al.
Clinical Genitourinary Cancer|July 19, 2015
(68)Ga-PSMA-PET/CT-Guided Salvage Retroperitoneal Lymph Node Dissection for Disease Relapse After Radical Prostatectomy for Prostate CancerRiccardo Schiavina, Francesco Ceci, Daniele Romagnoli, et al.
Clinical Genitourinary Cancer|March 19, 2018
Incidental Detection of Basaloid Thymic Carcinoma With <sup>68</sup>Ga-PSMA-11 PET/CT in a Patient With Recurrent Prostate CancerAndrea Farolfi, Francesco Ceci, Tiziano Graziani, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 2, 2015
(11)C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxelFrancesco Ceci, Paolo Castellucci, Tiziano Graziani, et al.
Cancers|May 11, 2024
Prostate-Specific Membrane Antigen-Targeted Therapy in Prostate Cancer: History, Combination Therapies, Trials, and Future PerspectiveFrancesco Mattana, Lorenzo Muraglia, Antonio Barone, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 16, 2018
<sup>68</sup>Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment strategyAndrea Farolfi, Francesco Ceci, Paolo Castellucci, et al.
EJNMMI Physics|February 27, 2021
Impact of segmentation and discretization on radiomic features in <sup>68</sup>Ga-DOTA-TOC PET/CT images of neuroendocrine tumorVirginia Liberini, Bruno De Santi, Osvaldo Rampado, et al.
Pageof 15

Showing results (41-50 of 148) with videos related to

Sort By:
Pageof 15
European Journal of Nuclear Medicine and Molecular Imaging|April 14, 2017
The role of <sup>18</sup>F-FDG PET/CT in the detection of osteosarcoma recurrenceAndrea Angelini, Francesco Ceci, Paolo Castellucci, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|June 11, 2024
Prostate cancer: nuclear medicine imaging in the biochemical recurrence and in oligometastatic diseaseLorenzo Muraglia, Egesta Lopci, Jelena Jandric, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 16, 2012
(11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomyFrancesco Ceci, Paolo Castellucci, Marcelo Mamede, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 8, 2019
Prediction nomogram for <sup>68</sup>Ga-PSMA-11 PET/CT in different clinical settings of PSA failure after radical treatment for prostate cancerFrancesco Ceci, Lorenzo Bianchi, Marco Borghesi, et al.
Clinical Genitourinary Cancer|July 19, 2015
(68)Ga-PSMA-PET/CT-Guided Salvage Retroperitoneal Lymph Node Dissection for Disease Relapse After Radical Prostatectomy for Prostate CancerRiccardo Schiavina, Francesco Ceci, Daniele Romagnoli, et al.
Clinical Genitourinary Cancer|March 19, 2018
Incidental Detection of Basaloid Thymic Carcinoma With <sup>68</sup>Ga-PSMA-11 PET/CT in a Patient With Recurrent Prostate CancerAndrea Farolfi, Francesco Ceci, Tiziano Graziani, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 2, 2015
(11)C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxelFrancesco Ceci, Paolo Castellucci, Tiziano Graziani, et al.
Cancers|May 11, 2024
Prostate-Specific Membrane Antigen-Targeted Therapy in Prostate Cancer: History, Combination Therapies, Trials, and Future PerspectiveFrancesco Mattana, Lorenzo Muraglia, Antonio Barone, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 16, 2018
<sup>68</sup>Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment strategyAndrea Farolfi, Francesco Ceci, Paolo Castellucci, et al.
EJNMMI Physics|February 27, 2021
Impact of segmentation and discretization on radiomic features in <sup>68</sup>Ga-DOTA-TOC PET/CT images of neuroendocrine tumorVirginia Liberini, Bruno De Santi, Osvaldo Rampado, et al.
Pageof 15